手機掃碼訪問本站
微信咨詢
猜你喜歡
- [S-(R*,S*)]-3,4-dimethoxy-alpha1-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-o-xylene-alpha,alpha’-diol
- trans Resveratrol-3,5-disulfate
- 甲基硫代乙酸甲酯
- 17beta-乙酰氧基-2alpha-溴-5alpha-雄甾烷酮
- 6-溴-2-(3-溴苯基)-喹啉-4-羧酸
- 3,4-Dihydro-6,7-diMethoxy-1-(p-Methoxybenzyl)isoquinoline Hydrochloride
- 甲基三正辛銨合雙(三氟甲烷磺酰)亞胺
- 2-乙酰基-3-甲基吡嗪
- 3-乙基噻吩
- 72509-76-3非洛地平的副作用
- 2,5,8-Undecatriyn-1-ol
- RALOXIFENE4-MONOMETHYLETHER
- 2-(4-羥基苯基)苯并[B]噻吩-6-醇
- 三(異丙基環(huán)戊二烯)化鐠
- (S)-(-)-N,N-二甲基-1-苯乙胺
- 7-AMino-2-chlorodibenz[b,f][1,4]oxazepine-11(10H)-one
- N-乙基乙二胺
- 320345-99-1/阿地溴銨治療中重度COPD患者療效分析
- 3-(2-噻吩-2-基乙酰基氨基)苯甲酸
- (2,2-DIMETHYL-TETRAHYDRO-PYRAN-4-YL)-METHYL-AMINE
- 84371-65-3 / 米非司酮的聯(lián)合用藥研究報道
- 1-CARBOXYPENTYL-2,3,3-TRIMETHYLINDOLENIUM-5-SULFATE, POTASSIUM SALT
- 2-(4-甲基嗎啉-2-基)乙醇
- 4-Hydroxy-3,5-diiodo-benzeneacetic Acid Methyl Ester
- 磷化鍶
